These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 29495537)

  • 21. Exposure of the HIV-1 broadly neutralizing antibody 10E8 MPER epitope on the membrane surface by gp41 transmembrane domain scaffolds.
    Oakes V; Torralba J; Rujas E; Nieva JL; Domene C; Apellaniz B
    Biochim Biophys Acta Biomembr; 2018 Jun; 1860(6):1259-1271. PubMed ID: 29477358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and immunological assessment of VLP-based immunogens exposing the membrane-proximal region of the HIV-1 gp41 protein.
    Benen TD; Tonks P; Kliche A; Kapzan R; Heeney JL; Wagner R
    J Biomed Sci; 2014 Aug; 21(1):79. PubMed ID: 25160824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flagellin Encoded in Gene-Based Vector Vaccines Is a Route-Dependent Immune Adjuvant.
    Rady HF; Dai G; Huang W; Shellito JE; Ramsay AJ
    PLoS One; 2016; 11(2):e0148701. PubMed ID: 26844553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles.
    Phogat S; Svehla K; Tang M; Spadaccini A; Muller J; Mascola J; Berkower I; Wyatt R
    Virology; 2008 Mar; 373(1):72-84. PubMed ID: 18155743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deletion of flagellin's hypervariable region abrogates antibody-mediated neutralization and systemic activation of TLR5-dependent immunity.
    Nempont C; Cayet D; Rumbo M; Bompard C; Villeret V; Sirard JC
    J Immunol; 2008 Aug; 181(3):2036-43. PubMed ID: 18641341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Rhinovirus Presenting 4E10 Epitope of HIV-1 MPER Elicits Neutralizing Antibodies in Human ICAM-1 Transgenic Mice.
    Yi G; Tu X; Bharaj P; Guo H; Zhang J; Shankar P; Manjunath N
    Mol Ther; 2015 Oct; 23(10):1663-70. PubMed ID: 26061648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV antigen incorporation within adenovirus hexon hypervariable 2 for a novel HIV vaccine approach.
    Matthews QL; Fatima A; Tang Y; Perry BA; Tsuruta Y; Komarova S; Timares L; Zhao C; Makarova N; Borovjagin AV; Stewart PL; Wu H; Blackwell JL; Curiel DT
    PLoS One; 2010 Jul; 5(7):e11815. PubMed ID: 20676400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity of recombinant human immunodeficiency virus type 1-like particles expressing gp41 derivatives in a pre-fusion state.
    Kim M; Qiao Z; Yu J; Montefiori D; Reinherz EL
    Vaccine; 2007 Jun; 25(27):5102-14. PubMed ID: 17055621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The development of HIV vaccines targeting gp41 membrane-proximal external region (MPER): challenges and prospects.
    Liu H; Su X; Si L; Lu L; Jiang S
    Protein Cell; 2018 Jul; 9(7):596-615. PubMed ID: 29667004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of HIV neutralizing antibodies against the MPER of the HIV envelope protein by HA/gp41 chimeric protein-based DNA and VLP vaccines.
    Ye L; Wen Z; Dong K; Wang X; Bu Z; Zhang H; Compans RW; Yang C
    PLoS One; 2011; 6(5):e14813. PubMed ID: 21625584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selection and immune recognition of HIV-1 MPER mimotopes.
    Wieczorek L; Peachman K; Steers N; Schoen J; Rao M; Polonis V; Rao V
    Virology; 2020 Nov; 550():99-108. PubMed ID: 32980676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction and immunological evaluation of dual cell surface display of HIV-1 gag and Salmonella enterica serovar Typhimurium FliC in Lactobacillus acidophilus for vaccine delivery.
    Kajikawa A; Zhang L; Long J; Nordone S; Stoeker L; LaVoy A; Bumgardner S; Klaenhammer T; Dean G
    Clin Vaccine Immunol; 2012 Sep; 19(9):1374-81. PubMed ID: 22761297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a trimeric MPER containing HIV-1 gp41 antigen.
    Hinz A; Schoehn G; Quendler H; Hulsik DL; Stiegler G; Katinger H; Seaman MS; Montefiori D; Weissenhorn W
    Virology; 2009 Aug; 390(2):221-7. PubMed ID: 19539967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The membrane-proximal external region of HIV-1 gp41: a vaccine target worth exploring.
    Zwick MB
    AIDS; 2005 Nov; 19(16):1725-37. PubMed ID: 16227780
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunisation with foamy virus Bet fusion proteins as novel strategy for HIV-1 epitope delivery.
    Mühle M; Hoffmann K; Löchelt M; Denner J
    Immunol Res; 2013 May; 56(1):61-72. PubMed ID: 23440699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of immune responses to an HIV env DNA vaccine by a C-terminal segment of listeriolysin O.
    Bu Z; Ye L; Skeen MJ; Ziegler HK; Compans RW; Yang C
    AIDS Res Hum Retroviruses; 2003 May; 19(5):409-20. PubMed ID: 12803999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin.
    Bargieri DY; Rosa DS; Braga CJ; Carvalho BO; Costa FT; Espíndola NM; Vaz AJ; Soares IS; Ferreira LC; Rodrigues MM
    Vaccine; 2008 Nov; 26(48):6132-42. PubMed ID: 18804504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of HIV-1 neutralization by antibodies targeting a membrane-proximal region of gp41.
    Chen J; Frey G; Peng H; Rits-Volloch S; Garrity J; Seaman MS; Chen B
    J Virol; 2014 Jan; 88(2):1249-58. PubMed ID: 24227838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The adjuvant activity of alphavirus replicons is enhanced by incorporating the microbial molecule flagellin into the replicon.
    Knudsen ML; Johansson DX; Kostic L; Nordström EK; Tegerstedt K; Pasetto A; Applequist SE; Ljungberg K; Sirard JC; Liljeström P
    PLoS One; 2013; 8(6):e65964. PubMed ID: 23785460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of mucosal HIV-specific B and T cell responses after oral immunization with live coxsackievirus B4 recombinants.
    Gu R; Stagnar C; Zaichenko L; Ramsingh AI
    Vaccine; 2012 May; 30(24):3666-74. PubMed ID: 22464964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.